To receive a free investor package or for more information, please email us at
[EMAIL PROTECTED]
****************************
Burcon NutraScience, Inc. is a publicly traded company that is developing the world's
first commercial canola protein, Puratein, which is recognized for its nutritional and
functional qualities. The company trades on the Canadian Venture Exchange under the
symbol TSX:BU.
BURCON ANNOUNCES SUPERTEIN -- FILES COMPOSITION PATENT
Vancouver, British Columbia, May 15, 2002 - Burcon NutraScience Corporation (TSX -BU)
("Burcon") announced today that it has filed a composition patent to protect
SuperteinT, the company's second novel canola protein isolate. This
low-molecular-weight canola protein exhibits both distinct and valuable functional and
nutritional profiles. Supertein complements PurateinT, Burcon's initial protein
isolate from canola.
For the remainder of this news release and to receive a free package on Burcon, please
contact us at [EMAIL PROTECTED] or 1-800-544-6001. If you would like to be taken
off of this list, please reply to [EMAIL PROTECTED] You can also visit Burcon's
web site at www.burcon.ca.
_________________________________________
Disclaimer: Rock Capital was paid $1,000 Cdn. by a third party for this distribution.
Rock Capital does not own stock in Burcon and is not affiliated with Burcon. The words
and claims contained in this report are those of Burcon NutraScience. The information
in this email has been gathered from sources deemed to be correct. Rock Capital takes
no responsibility for the accuracy or adequacy of the information in this email and
encourages you to consult with your investment advisor regarding all investment
decisions. This notice shall not constitute an offer to sell or the solicitation of an
offer to buy nor shall there be any sale of these securities in any state in which
such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state. Please check with a
professional investment advisor or with the company to determine whether these
securities may be purchased or sold in your state of residence prior to ef!
fecting a transaction.
